Literature DB >> 27386459

Successful Treatment of Paecilomyces lilacinus Onychomycosis with Efinaconazole and Tavaborole.

John M Evans1, Apphia L Wang2, Boni E Elewski2.   

Abstract

Paecilomyces lilacinus, also known as Purpureocillium lilacinum, is a non-dermatophyte mold found in the soil and used as nematocide for crops. P. lilacinus can cause rare opportunistic infections in humans ranging from endocarditis, keratitis, to onychomycosis with significant resistance to conventional antifungals. There are only two cases of onychomycosis caused by P. lilacinus reported in the literature and none that were successfully treated. Here we present a case of successfully treated onychomycosis caused by P. lilacinus with efinaconazole and tavaborole in a patient who had failed treatment with oral fluconazole, itraconazole, terbinafine, and topical ciclopirox and naftifine.

Entities:  

Keywords:  Efinaconazole; Non-dermatophyte; Onychomycosis; Paecilomyces lilacinus; Purpureocillium lilacinum; Tavaborole; Treatment

Year:  2016        PMID: 27386459      PMCID: PMC4908444          DOI: 10.1159/000443773

Source DB:  PubMed          Journal:  Skin Appendage Disord        ISSN: 2296-9160


  11 in total

1.  Purpureocillium, a new genus for the medically important Paecilomyces lilacinus.

Authors:  Jennifer Luangsa-Ard; Jos Houbraken; Tineke van Doorn; Seung-Beom Hong; Andrew M Borman; Nigel L Hywel-Jones; Robert A Samson
Journal:  FEMS Microbiol Lett       Date:  2011-06-23       Impact factor: 2.742

2.  Tavaborole for the treatment of onychomycosis.

Authors:  Boni E Elewski; Antonella Tosti
Journal:  Expert Opin Pharmacother       Date:  2014-05-26       Impact factor: 3.889

Review 3.  Onychomycosis caused by infection with Paecilomyces lilacinus.

Authors:  C L Fletcher; R J Hay; G Midgley; M Moore
Journal:  Br J Dermatol       Date:  1998-12       Impact factor: 9.302

4.  Persisting Paecilomyces lilacinus nail infection following pregnancy.

Authors:  Patrizia Innocenti; Elisabetta Pagani; Dunja Vigl; Reinhard Höpfl; Hartwig P Huemer; Clara Larcher
Journal:  Mycoses       Date:  2011-05-25       Impact factor: 4.377

Review 5.  Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections.

Authors:  F J Pastor; J Guarro
Journal:  Clin Microbiol Infect       Date:  2006-10       Impact factor: 8.067

Review 6.  Utilization of the internal transcribed spacer regions as molecular targets to detect and identify human fungal pathogens.

Authors:  P C Iwen; S H Hinrichs; M E Rupp
Journal:  Med Mycol       Date:  2002-02       Impact factor: 4.076

Review 7.  Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus: report of three cases and review of the literature.

Authors:  Virginia C Hall; Sanjiva Goyal; Mark D P Davis; John S Walsh
Journal:  Int J Dermatol       Date:  2004-09       Impact factor: 2.736

Review 8.  The role of topical antifungal therapy for onychomycosis and the emergence of newer agents.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2014-07

9.  Susceptibility testing and molecular classification of Paecilomyces spp.

Authors:  Maria Victoria Castelli; Ana Alastruey-Izquierdo; Isabel Cuesta; Araceli Monzon; Emilia Mellado; Juan L Rodriguez-Tudela; Manuel Cuenca-Estrella
Journal:  Antimicrob Agents Chemother       Date:  2008-06-02       Impact factor: 5.191

10.  Antifungal susceptibilities of Paecilomyces species.

Authors:  C Aguilar; I Pujol; J Sala; J Guarro
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

View more
  5 in total

1.  Transcriptomic studies on Purpureocillium lilacinum reveal molecular mechanisms of response to fluconazole and itraconazole.

Authors:  Rafael Pedezzi; Carlos Alberto Oliveira de Biagi Junior; Marcela Cristina Corrêa de Freitas; Nathália Gonsales da Rosa-Garzon; Hamilton Cabral
Journal:  Braz J Microbiol       Date:  2021-03-02       Impact factor: 2.476

Review 2.  Newer Topical Treatments in Skin and Nail Dermatophyte Infections.

Authors:  Kanika Sahni; Sanjay Singh; Sunil Dogra
Journal:  Indian Dermatol Online J       Date:  2018 May-Jun

Review 3.  Human Pathogenic Paecilomyces from Food.

Authors:  Danielly C Moreira; Manoel M E Oliveira; Cintia M Borba
Journal:  Microorganisms       Date:  2018-07-05

4.  An unusual case of hyalohyphomycosis due to Purpureocillium lilacinum in a patient with myasthenia gravis.

Authors:  Ramya Raghavan; Gomathi Chithra; Sanal Fernandez; Bettadpura Shamana Suryanarayana; Rakesh Singh
Journal:  Curr Med Mycol       Date:  2018-06

5.  Cutaneous dermatomycosis with concurrent Paecilomyces lilacinus and Candida guilliermondii in a patient with longstanding diabetes.

Authors:  Sharon Kam; Alexander B Hicks; Ban M Allos; Alan S Boyd
Journal:  JAAD Case Rep       Date:  2021-11-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.